Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Services » Servicestothe Health Industry
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| DGX | Quest Diagnostics, Inc. | -1.99% | 109.10 | 4.3% | $193.18m | |
| IQV | IQVIA Holdings, Inc. | -0.68% | 147.95 | 0.0% | $155.31m | |
| LH | Laboratory Corp. of America Holdings | -0.48% | 177.82 | 2.4% | $147.15m | |
| SYNH | Syneos Health, Inc. | -1.19% | 51.29 | 0.0% | $42.38m | |
| AMEH | Apollo Medical Holdings, Inc. | 0.92% | 16.48 | 0.0% | $3.08m | |
| NRC | National Research Corp. | 0.50% | 46.74 | 0.0% | $1.43m | |
| IDXG | Interpace Biosciences, Inc. | -5.06% | 3.00 | 22.8% | $0.57m | |
| PLX | Protalix Biotherapeutics, Inc. | 2.85% | 3.61 | 26.0% | $0.29m | |
| PMD | Psychemedics Corp. | -2.46% | 4.37 | 0.7% | $0.11m | |
| BASI | Bioanalytical Systems, Inc. | -2.46% | 4.76 | 0.2% | $0.07m |
Company Profile
Syneos Health, Inc. provides outsourced clinical development and commercialization services to biopharmaceutical companies. It operates through the following business segments: Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers clinical development services spanning Phase I to Phase IV, including global studies, as well as unbundled service offerings such as clinical monitoring, investigator recruitment, patient recruitment, data management, and study startup to assist customers with their drug development process. The Commercial Solutions segment provides commercialization services, including outsourced field selling solutions, medication adherence, communications, and consulting services. The company was founded in 1998 and is headquartered in Morrisville, NC.